Merck Millipore has confirmed the shutdown of the chromatography company SeQuant in Umeå, Sweden.
Resources and functions based in Umeå will be transferred to Darmstadt Germany and Millipore AB in Sweden. The transmission will enable Merck Millipore to continue to develop its analytical chromatography portfolio using SeQuants technology resources.
Novo Nordisk has announced plans to invest DKK 850 million in expanding its production facilities in Kalundborg, Denmark. This new investment brings Novo Nordisk’s total investments in site Kalundborg to more than DKK 2 billion in 2020. Novo Nordisk currently manufactures a range of diabetes care products in Kalundborg, and…
Norwegian company Oncoinvent has announced the closing of a 210 MNOK (approx. 25 MUSD) private placement of ordinary shares. Large privately owned investment companies joining the company as new investors include Geveran Trading Co. Ltd., Canica AS, CGS Holding AS, Helene Sundt AS and Must Invest AS. Oncoinvent AS is…
AstraZeneca and MSD’s Lynparza has been approved in China for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to 1st-line platinum-based chemotherapy in combination with bevacizumab, and whose cancer is associated with homologous recombination deficiency…
Meda has signed an agreement to divest the manufacturing unit in Lakewood, New Jersey. The manufacturing unit will be divested to the contract manufacturer DPT. According to Meda the manufacturing facility is dedicated to global supply of the product MUSE. As part of the agreement Meda has entered into a long…
